PAX3 and alveolar rhabdomyosarcoma: To test whether PAX3-FOXO1 was required for ATR inhibitor sensitivity, we induced the expression of shRNAs directed against PAX3-FOXO1 mRNA in PAX3-FOXO1-expressing ARMS cells (Fig. 4h).